Dendritic cell therapy: Phase I and II Update

Patients will receive two monthly infusions of autologous dendritic cells activated ex vivo with prostate

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE